Ressources

cell-background
Publications

Paediatric Liver Cancer

A preclinical platform of mouse-transplanted human pediatric liver tumors to evaluate the efficacy of conventional and innovative anticancer therapy

triangleDiscover
Publications

Paediatric Liver Cancer

Liver cancer patient-derived xenografts to improve disease management in childhood and adolescence: perspectives and challenges of personalized medicine

triangleDiscover
Publications

Paediatric Liver Cancer

A panel of pediatric liver cancer patient-derived xenografts to improve stratification of children with hepatoblastoma

triangleDiscover
Publications

2D PDX-derived primary cultures

A new and fast in vitro screen to predict in vivo drug efficacy using cell primary culture from patient derived tumor established xenografts

triangleDiscover
news

XenTech remains fully operational after 7 weeks of COVID-19 pandemic : update from our COO

In this 7th week of containment and as end of confinement in France is announced for May 11th, I would first of all like to thank you on behalf of our teams for all the messages of support you have sent us since the beginning of the COVID-19 crisis.

triangleDiscover
news

XenTech Covid-19 management

Regarding the current circumstances, we at XenTech want you to know that we are taking the Covid-19 pandemia very seriously. We are closely monitoring the pandemic, following guidance and advice from the World Health Organization (WHO), and the French Government. 

triangleDiscover
publications

Paediatric Liver Cancer

A preclinical platform of mouse-transplanted human pediatric liver tumors to evaluate the efficacy of conventional and innovative anticancer therapy

triangleDiscover
publications

Paediatric Liver Cancer

Liver cancer patient-derived xenografts to improve disease management in childhood and adolescence: perspectives and challenges of personalized medicine

triangleDiscover
publications

Paediatric Liver Cancer

A panel of pediatric liver cancer patient-derived xenografts to improve stratification of children with hepatoblastoma

triangleDiscover
publications

2D PDX-derived primary cultures

A new and fast in vitro screen to predict in vivo drug efficacy using cell primary culture from patient derived tumor established xenografts

triangleDiscover

01Conferences
& events

09.20.21

XenTech will attend BIOPHARM-US

We’ll be delighted to present you the new products and services, reach out to us !  

triangleDiscover
07.16.21

XenTech exhibits at AACR digital-Annual Meeting 2021

Please get in touch with our team, we’ll be delighted to present you many new products and services we worked-out to extend our service offering :

triangleDiscover
07.31.21

XenTech will attend 11th World ADC EU (March 8-11 2021), e-Meet you there !

triangleDiscover
07.17.21

Connect with us during Digital Biofit 2020 !

triangleDiscover
cell-background

03Discover more

About us

triangleDiscover
xentech-live

Contact us

triangleDiscover